Consensus clustering and novel risk score model construction based on m6A methylation regulators to evaluate the prognosis and tumor immune microenvironment of early-stage lung adenocarcinoma
Figure 8.The expression of HNRNPC, IGF2BP1 and IGF2BP3 in early-stage LUAD was verified by RT-PCR. * represents P<0.05.